Tuberculosis is on the rise again. We can fight it — if we try
Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.
manilatimes17m
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...
Le Lézard32m
Teva and Alvotech Announce SELARSDItm (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
sanews21m
Cabinet briefed on implications of aid funding withdrawal
Cabinet says it has been briefed about the withdrawal of aid funding by the United States (US) government and its ...